Saturday 17 October 2026 Export QNRX’s income statement to Excel — free account

Quoin Pharmaceuticals, Ltd. Sponsored ADR

In the quarter to June 2026, EPS grew 69.8% and free cash flow fell 510.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.90 0.13 −3.23%

Follow QNRX

Alert me

Market cap: $8.1M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(575.73%)	(231.17%)	(141.59%)	(651.40%)	+8 more TTM periods Free account
ROA Full definition →	(178.77%)	(118.61%)	(87.56%)	(154.58%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(371.60%)	(170.10%)	(109.30%)	(5,491.66%)
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(5.39)	(5.59)	(12.68)	(18.26)
Free Cash Flow Full definition →	(15.27)	(15.82)	(13.54)	(10.74)
Other line items
Cash ROIC Full definition →	(103.67%)	(69.32%)	(42.49%)	(255.89%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.82	0.93	0.86	0.78
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(5.39)	(5.59)	(12.68)	(18.26)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly